Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The blood glucose monitoring market is significantly influenced by various market factors that collectively shape its dynamics and growth trajectory. One of the primary drivers is the increasing prevalence of diabetes globally. As the number of individuals diagnosed with diabetes continues to rise, the demand for effective and efficient blood glucose monitoring devices also grows. This surge in demand is further fueled by the growing awareness among patients about the importance of regular blood glucose monitoring in managing diabetes.
Technological advancements play a pivotal role in shaping the blood glucose monitoring market. The continuous development of innovative monitoring devices, such as continuous glucose monitoring (CGM) systems and smart glucose meters, has revolutionized the way individuals manage their diabetes. These technologically advanced devices offer real-time monitoring, data analysis, and connectivity features, providing patients and healthcare professionals with valuable insights into glucose levels and trends. As a result, the market is witnessing a shift towards these advanced technologies, contributing to overall market growth.
Government initiatives and healthcare policies also significantly impact the blood glucose monitoring market. Many governments worldwide are actively promoting diabetes management programs and offering subsidies for glucose monitoring devices to improve patient outcomes. These initiatives aim to reduce the economic burden associated with diabetes-related complications and hospitalizations. The supportive regulatory environment further encourages market players to invest in research and development, fostering innovation in blood glucose monitoring solutions.
The increasing geriatric population is another key factor driving the blood glucose monitoring market. Elderly individuals are more susceptible to diabetes, and the rising aging population contributes to the overall growth in the number of diabetes cases. As a result, there is a higher demand for reliable and user-friendly blood glucose monitoring devices tailored to the specific needs of older adults. Market players are responding to this demand by developing products with features such as large, easy-to-read displays and simplified user interfaces.
Furthermore, lifestyle changes and dietary habits significantly impact the prevalence of diabetes, consequently influencing the blood glucose monitoring market. Unhealthy lifestyles, sedentary behavior, and poor dietary choices contribute to the increasing incidence of diabetes globally. This has created a substantial market opportunity for blood glucose monitoring devices as individuals seek effective tools to manage their condition and make informed lifestyle choices.
Competitive dynamics within the market are shaped by factors such as mergers and acquisitions, collaborations, and strategic partnerships. Companies are actively engaging in these activities to strengthen their product portfolios, expand market presence, and leverage complementary technologies. The competitive landscape is evolving, with a focus on offering integrated solutions that combine monitoring devices with data management platforms and telehealth services.
EMEA Blood Glucose Monitoring Market Highlights:
EMEA Blood Glucose Monitoring Market Overview
EMEA Blood Glucose Monitoring Market Size was valued at USD 7.62 Billion in 2023. The EMEA Blood Glucose Monitoring industry is projected to grow from USD 8.03 Billion in 2024 to USD 14.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.99% during the forecast period (2024 - 2032).
One of the main objectives of diabetes treatment is to keep blood glucose level within a specified target range. Blood glucose monitoring is a process, which helps to identify the blood glucose level and notify if glucose level of blood is exceeding the limit. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well as monitor the effect of diabetes meditation on blood sugar level and understand the effect of illness and stress on the blood sugar level.
The EMEA blood glucose monitoring market is growing rapidly owing to the increasing prevalence of diabetes, innovative technology for monitoring and diagnosis of diabetes, early detection of diabetes, and increasing demand for continuous glucose monitoring devices.
Various blood glucose monitoring devices are available in the Europe and the Middle East and African market, which is referred as blood glucose meter. These devices help to identify the blood glucose level at home, clinics, hospitals, etc. Furthermore, they are designed to apply to the different type of diabetes such as Type 1 and Type 2.
Increasing diabetic patient in the Europe has increased the blood glucose monitoring devices market. Different types of glucose monitoring devices are available in the market such as blood glucose meter, continuous glucose monitoring system, Lancets, glucose monitoring strips, and others. Self-monitoring devices are the oldest method for monitoring blood glucose level and are widely used in home, hospital, and clinics.
EMEA Blood Glucose Monitoring Market Segment Insights
EMEA Blood Glucose Monitoring Product Type Insights
On the basis of the product type, the EMEA blood glucose monitoring market is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.
Europe, the Middle East, and Africa Blood Glucose Monitoring Application Insights
On the basis of the application, EMEA blood glucose monitoring market is segmented into type 1 diabetes, type 2 diabetes, and others.
EMEA Blood Glucose Monitoring End User Insights
On the basis of the end user, EMEA blood glucose monitoring market is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.
Europe, the Middle East, and Africa Blood Glucose Monitoring Regional Insights
On the regional basis, Europe, Middle East, and Africa blood glucose monitoring market is segmented into two major regions Europe and the Middle East and Africa.
Europe blood glucose monitoring devices market is showing swift growth owing to the increasing diabetic and obese population, unhealthy food, lack of exercise, and many another factor. Europe is leading the market growth with 60% of market share of EMEA market. According to the WHO, in 2016, around 60 million people had diabetes, and its prevalence is increasing in all age groups in Europe.
The Middle East and Africa account for the least share of market owing to poor political conditions in Africa and limited availability of funds and availability of medical facilities but, sound growth is expected over the review period. The Middle East holds the major share of the Middle East & African market due to the presence of well-developed countries like Kuwait, Qatar, Oman and South Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market.
EMEA Blood Glucose Monitoring Market Key Players
Some of the key players in this market are:
- Abbott Laboratories (US)
- Arkay Inc. (Japan)
- Bayer Healthcare AG, (Germany)
- F.Hoffmann-La Roche (Switzerland)
- LifeScan
- Johnson & Johnson (U.S.)
- Medtronic plc.
- Nipro Diagnostics Inc.
- Terumo Medical Corporation
Intended Audience
- Blood Glucose Monitoring Devices Suppliers
- Blood Glucose Monitoring Devices Manufacturers
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
